scispace - formally typeset
J

Judy K. Shigenaga

Researcher at University of California, San Francisco

Publications -  70
Citations -  7418

Judy K. Shigenaga is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Tumor necrosis factor alpha & Receptor. The author has an hindex of 43, co-authored 69 publications receiving 6908 citations. Previous affiliations of Judy K. Shigenaga include United States Department of Veterans Affairs & San Francisco General Hospital.

Papers
More filters
Journal ArticleDOI

Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host.

TL;DR: APR-induced alterations initially protect the host from the harmful effects of bacteria, viruses, and parasites, however, if prolonged, these changes in the structure and function of lipoproteins will contribute to atherogenesis.
Journal ArticleDOI

Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.

TL;DR: In this article, the authors studied plasma lipids, lipoproteins, triglyceride (TG) metabolism, and serum cytokines in three groups: patients with the acquired immunodeficiency syndrome (AIDS) without active secondary infection, patients with evidence of HIV infection but without clinical AIDS (HIV+), and controls.
Journal ArticleDOI

Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance.

TL;DR: The data suggest that neither of these cytokines is absolutely required for the increase in serum triglycerides induced by LPS, raising the possibility that other cytokines, small molecular mediators, or LPS itself may play a crucial role.
Journal ArticleDOI

Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.

TL;DR: HIV+ and AIDS are able to partially compensate for increased REE because they do not show short-term weight loss, and rapid weight loss with anorexia may be a harbinger of secondary infection in AIDS.
Journal ArticleDOI

The acute phase response is associated with retinoid X receptor repression in rodent liver.

TL;DR: It is demonstrated that lipopolysaccharide (LPS) induces a rapid, dose-dependent decrease in RXRα, RXRβ, and RXRγ proteins in hamster liver, and increased RNA degradation is likely responsible for the repression of RXR.